{"id":2499,"date":"2021-10-01T11:08:27","date_gmt":"2021-10-01T16:08:27","guid":{"rendered":"https:\/\/lsom.uthscsa.edu\/nephrology\/?post_type=clinical-trail&#038;p=2499"},"modified":"2021-11-22T11:03:09","modified_gmt":"2021-11-22T17:03:09","slug":"applause-igan-clinical-trial","status":"publish","type":"clinical-trial","link":"https:\/\/lsom.uthscsa.edu\/nephrology\/clinical-trial\/applause-igan-clinical-trial\/","title":{"rendered":"APPLAUSE-IgAN Clinical Trial"},"excerpt":{"rendered":"<p>Currently there are no evidence-based disease-modifying pharmacotherapies for IgAN. The purpose of this clinical trial is to evaluate the superiority of LNP023 (a factor B inhibitor which works by damping the innate immune system) versus placebo on top of the maximally tolerated doses of an ACEi or ARB in slowing kidney disease progression and reduction in the protein in the urine.<\/p>\n","protected":false},"featured_media":0,"template":"","clinical-trial-category":[],"age-requirement":[29,39,30,31,32,33,34,35,36],"diagnosed":[40],"class_list":["post-2499","clinical-trial","type-clinical-trial","status-publish","hentry","age-requirement-18-years-or-older","age-requirement-22-years-or-older","age-requirement-45-years-or-older","age-requirement-50-years-or-older","age-requirement-55-years-or-older","age-requirement-60-years-or-older","age-requirement-65-years-or-older","age-requirement-70-years-or-older","age-requirement-75-years-or-older","diagnosed-iga-nephropathy-igan"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>APPLAUSE-IgAN Clinical Trial - Nephrology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lsom.uthscsa.edu\/nephrology\/clinical-trial\/applause-igan-clinical-trial\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"APPLAUSE-IgAN Clinical Trial - Nephrology\" \/>\n<meta property=\"og:description\" content=\"Currently there are no evidence-based disease-modifying pharmacotherapies for IgAN. The purpose of this clinical trial is to evaluate the superiority of LNP023 (a factor B inhibitor which works by damping the innate immune system) versus placebo on top of the maximally tolerated doses of an ACEi or ARB in slowing kidney disease progression and reduction in the protein in the urine.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lsom.uthscsa.edu\/nephrology\/clinical-trial\/applause-igan-clinical-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"Nephrology\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-22T17:03:09+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/clinical-trial\\\/applause-igan-clinical-trial\\\/\",\"url\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/clinical-trial\\\/applause-igan-clinical-trial\\\/\",\"name\":\"APPLAUSE-IgAN Clinical Trial - Nephrology\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/#website\"},\"datePublished\":\"2021-10-01T16:08:27+00:00\",\"dateModified\":\"2021-11-22T17:03:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/clinical-trial\\\/applause-igan-clinical-trial\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/clinical-trial\\\/applause-igan-clinical-trial\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/clinical-trial\\\/applause-igan-clinical-trial\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clinical Trials\",\"item\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/clinical-trial\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"APPLAUSE-IgAN Clinical Trial\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/#website\",\"url\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/\",\"name\":\"Nephrology\",\"description\":\"Division of Nephrology\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/nephrology\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"APPLAUSE-IgAN Clinical Trial - Nephrology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lsom.uthscsa.edu\/nephrology\/clinical-trial\/applause-igan-clinical-trial\/","og_locale":"en_US","og_type":"article","og_title":"APPLAUSE-IgAN Clinical Trial - Nephrology","og_description":"Currently there are no evidence-based disease-modifying pharmacotherapies for IgAN. The purpose of this clinical trial is to evaluate the superiority of LNP023 (a factor B inhibitor which works by damping the innate immune system) versus placebo on top of the maximally tolerated doses of an ACEi or ARB in slowing kidney disease progression and reduction in the protein in the urine.","og_url":"https:\/\/lsom.uthscsa.edu\/nephrology\/clinical-trial\/applause-igan-clinical-trial\/","og_site_name":"Nephrology","article_modified_time":"2021-11-22T17:03:09+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/clinical-trial\/applause-igan-clinical-trial\/","url":"https:\/\/lsom.uthscsa.edu\/nephrology\/clinical-trial\/applause-igan-clinical-trial\/","name":"APPLAUSE-IgAN Clinical Trial - Nephrology","isPartOf":{"@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/#website"},"datePublished":"2021-10-01T16:08:27+00:00","dateModified":"2021-11-22T17:03:09+00:00","breadcrumb":{"@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/clinical-trial\/applause-igan-clinical-trial\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lsom.uthscsa.edu\/nephrology\/clinical-trial\/applause-igan-clinical-trial\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/clinical-trial\/applause-igan-clinical-trial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/lsom.uthscsa.edu\/nephrology\/"},{"@type":"ListItem","position":2,"name":"Clinical Trials","item":"https:\/\/lsom.uthscsa.edu\/nephrology\/clinical-trial\/"},{"@type":"ListItem","position":3,"name":"APPLAUSE-IgAN Clinical Trial"}]},{"@type":"WebSite","@id":"https:\/\/lsom.uthscsa.edu\/nephrology\/#website","url":"https:\/\/lsom.uthscsa.edu\/nephrology\/","name":"Nephrology","description":"Division of Nephrology","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lsom.uthscsa.edu\/nephrology\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/clinical-trial\/2499","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/clinical-trial"}],"about":[{"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/types\/clinical-trial"}],"wp:attachment":[{"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/media?parent=2499"}],"wp:term":[{"taxonomy":"clinical-trial-category","embeddable":true,"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/clinical-trial-category?post=2499"},{"taxonomy":"age-requirement","embeddable":true,"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/age-requirement?post=2499"},{"taxonomy":"diagnosed","embeddable":true,"href":"https:\/\/lsom.uthscsa.edu\/nephrology\/wp-json\/wp\/v2\/diagnosed?post=2499"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}